Markets
Security | Price | % ▲ | Buy | Sell | Target price | Potential |
---|---|---|---|---|---|---|
Amplitude Surgical SAS |
€3.08
02.08.24 |
- | 0 | 0 | - | - |
Ibex Techs Inc. |
€0.97
11.04.24 |
- | 0 | 0 | - | - |
Luye Pharma Group |
€0.33
02.08.24 |
- | 0 | 0 | - | - |
MEI Pharma Inc. |
€4.38
22.07.23 |
- | 7 | 0 | - | - |
Clovis Oncology Inc. |
€0.077
03.04.23 |
- | 0 | 0 | - | - |
X T L Biopharmaceuticals Ltd ADR |
€2.48
02.08.24 |
- | 0 | 0 | - | - |
Novan Inc |
€0.001
19.09.23 |
-97.780% | 0 | 22 | - | - |
Lannett Co. Inc. |
€0.015
03.05.23 |
-86.360% | 0 | 0 | - | - |
Invitae Corp |
€0.083
16.02.24 |
-78.840% | 0 | 0 | - | - |
Immune Pharmaceuticals Inc |
€0.001
27.07.22 |
-75.000% | 0 | 0 | - | - |
MagForce AG |
€0.001
02.08.24 |
-50.000% | 0 | 0 | - | - |
T2 Biosystems Inc. |
€0.16
20.11.23 |
-44.060% | 0 | 6 | - | - |
Elanix Biotechnologies AG |
€0.041
04.08.23 |
-41.180% | 0 | 0 | - | - |
Institut Biophytis Sas |
€0.000
02.05.24 |
-40.000% | 0 | 0 | - | - |
Surgalign Holdings Inc. |
€0.015
12.07.23 |
-39.530% | 0 | 0 | - | - |
Aceragen Inc. |
€0.45
09.10.23 |
-39.430% | 0 | 0 | - | - |
Summit Therapeutics plc |
€0.20
24.02.20 |
-33.450% | 0 | 0 | - | - |
Invictus MD Strategies |
€0.023
03.03.20 |
-31.820% | 1 | 0 | - | - |
Histogenics Corp. |
€0.14
30.09.19 |
-30.940% | 0 | 0 | - | - |
CVR Medical Corp |
€0.015
13.10.20 |
-30.770% | 0 | 0 | - | - |
Edesa Biotech Inc |
€0.39
20.11.23 |
-28.770% | 5 | 0 | €19.61 | 4966.047% |
iBio Inc. |
€0.18
28.11.23 |
-28.520% | 3 | 2 | €4.59 | 2406.011% |
Spineway |
€0.001
26.02.24 |
-27.270% | 1 | 0 | €1.80 | 224900.000% |
Scryb Inc. |
€0.011
02.08.24 |
-26.670% | 0 | 0 | - | - |
Elexxion AG |
€0.020
02.08.24 |
-25.930% | 0 | 0 | - | - |
Kazia Therapeutics |
€0.042
10.11.23 |
-25.220% | 0 | 0 | - | - |
Heat Biologics Inc. |
€0.069
14.06.24 |
-24.860% | 0 | 0 | - | - |
Nuvectra Corp |
€0.10
13.12.19 |
-23.080% | 0 | 0 | - | - |
Zecotek Photonics Inc. |
€0.008
05.12.19 |
-21.740% | 0 | 0 | - | - |
StageZero Life Sciences Ltd. |
€0.016
17.04.24 |
-20.510% | 0 | 0 | - | - |